Biomarkers in cystic fibrosis lung disease – a review

[1]Fuchs A, Gotta V, Decker M-L, Szinnai G, Baumann P, Bonhoeffer J., Ritzet N., Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial. Clin Microbiol Infect 2018; 24: 1341.e1–1341.e7 doi:10.1016/j.cmi.2018.03.016FuchsAGottaVDeckerM-LSzinnaiGBaumannPBonhoefferJ.RitzetN.Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trialClin Microbiol Infect2018241341e1–1341.e710.1016/j.cmi.2018.03.01629555393Open DOISearch in Google Scholar

[2]Ciuca IM, Pop L, Horhat F.G., Rogobete AF, Role of biomarkers in cystic fibrosis pulmonary disease, Pediatru.ro 2017; 46(2): 8–10 doi: 10.26416/Pedi.46.2.2017.806CiucaIMPopLHorhatF.G.RogobeteAFRole of biomarkers in cystic fibrosis pulmonary diseasePediatru.ro201746281010.26416/Pedi.46.2.2017.806Open DOISearch in Google Scholar

[3]Wallace, R. G., Twomey, L. C., Custaud, M. A., Moyna, N., Cummins, P. M., Mangone, M., & Murphy, R. P. (2016). Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment. BioMed Research International, 2016, [2465763]. https://doi.org/10.1155/2016/2465763WallaceR. G.TwomeyL. C.CustaudM. A.MoynaN.CumminsP. M.MangoneM.&MurphyR. P.2016Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment.BioMed Research International20162465763https://doi.org/10.1155/2016/246576310.1155/2016/2465763474976826942189Search in Google Scholar

[4]Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc 2007; 4(4):406–417. doi:10.1513/pats.200703-044BRSagelSDChmielJFKonstanMWSputum biomarkers of inflammation in cystic fibrosis lung disease.Proc Am Thorac Soc20074440641710.1513/pats.200703-044BR264760517652508Open DOISearch in Google Scholar

[5]Bedreag OH, Sandesc D, Chiriac SD, Rogobete AF, Cradigati AC, Sarandan M, Papurica M et al. The Use of Circulating miR-NAs as Biomarkers for Oxidative Stress in Critically Ill Poly-trauma Patients. Clinical Laboratory. 2016; 62(3):263–274. DOI: 10.7754/clin.lab.2015.150740.BedreagOHSandescDChiriacSDRogobeteAFCradigatiACSarandanMPapuricaMet al.The Use of Circulating miR-NAs as Biomarkers for Oxidative Stress in Critically Ill Poly-trauma Patients.Clinical Laboratory201662326327410.7754/clin.lab.2015.150740.Open DOISearch in Google Scholar

[6]Dumache R, Rogobete AF, Bedreag OH, Sarandan M, Cradigati AC , Papurica M, Corina Dumbuleu M, et al. Use of miR-NAs as biomarkers in sepsis. Anal Cell Pathol (Amst) 2015; 2015:186716. doi:10.1155/2015/186716DumacheRRogobeteAFBedreagOHSarandanMCradigatiACPapuricaMCorinaDumbuleu Met al.Use of miR-NAs as biomarkers in sepsisAnal Cell Pathol (Amst)2015201518671610.1155/2015/186716449937526221578Open DOISearch in Google Scholar

[7]Quon BS, Ngan DA, Wilcox PG, Man SFP, Sin DD (2014) Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis. PLOS ONE 9(2): e89341. https://doi.org/10.1371/journal.pone.0089341QuonBSNganDAWilcoxPGManSFPSinDD2014Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis.PLOS ONE92e89341https://doi.org/10.1371/journal.pone.008934110.1371/journal.pone.0089341393071824586701Search in Google Scholar

[8]Ranganathan SC, Hall GL, Sly PD, Stick SM, Douglas TA; Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It? Am J Respir Crit Care Med 2017; 195(12):1567–1575. doi:10.1164/rccm.201606-1107CIRanganathanSCHallGLSlyPDStickSMDouglasTAEarly Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?Am J Respir Crit Care Med2017195121567157510.1164/rccm.201606-1107CI685072527911585Open DOISearch in Google Scholar

[9]Decraene A, Willems-Widyastuti A, Kasran A, De Boeck K, Bullens DM, Dupont LJ. Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients. Respir Res 2010; 11(1): 177. doi:10.1186/1465-9921-11-177 2010, 11:177DecraeneAWillems-WidyastutiAKasranADeBoeck KBullensDMDupontLJElevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patientsRespir Res201011117710.1186/1465-9921-11-1772010, 11177Open DOISearch in Google Scholar

[10]Rao JR, Nelson D, Moore JE, Millar BC, Goldsmith CE, Rendall J, Elborn JS. Non-coding small (micro) RNAs of Pseudomonas aeruginosa isolated from clinical isolates from adult patients with cystic fibrosis. Br J Biomed Sci 2010; 67(3): 126–132 . doi:10.1 080/09674845.2010.11730309.RaoJRNelsonDMooreJEMillarBCGoldsmithCERendallJElbornJSNon-coding small (micro) RNAs of Pseudomonas aeruginosa isolated from clinical isolates from adult patients with cystic fibrosisBr J Biomed Sci201067312613210.1080/09674845.2010.11730309.20973407Open DOISearch in Google Scholar

[11]Tsuchiya M, Kumar P, Bhattacharyya S, Chattoraj S, Srivastava M, Pollard HB, Biswas R. Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells. J Interferon Cytokine Res 2013; 33(3): 121–129. doi:10.1089/ jir.2012.0074TsuchiyaMKumarPBhattacharyyaSChattorajSSrivastavaMPollardHBBiswasRDifferential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cellsJ Interferon Cytokine Res201333312112910.1089/jir.2012.0074Open DOISearch in Google Scholar

[12]Bedreag, O. , Rogobete, A. , Dumache, R. , Sarandan, M. , Cradigati, A. , Papurica, M. , Craciunescu, M. , Sandesc, D. et al. (2015). Use of circulating microRNAs as biomarkers in critically ill polytrauma patients. Biomarkers and Genomic Medicine 2016, 7(4): 131–138 doi: 10.1016/j.bgm.2015.11.002BedreagO.RogobeteA.DumacheR.SarandanM.CradigatiA.PapuricaM. CraciunescuM.SandescD.et al.2015Use of circulating microRNAs as biomarkers in critically ill polytrauma patients.Biomarkers and Genomic Medicine20167413113810.1016/j.bgm.2015.11.002Open DOISearch in Google Scholar

[13]Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003; 2(1): 29–34. doi:10.1016/S1569-1993(02)00141-8LeeTWBrownleeKGConwaySPDentonMLittlewoodJMEvaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.J Cyst Fibros200321293410.1016/S1569-1993(02)00141-8Open DOISearch in Google Scholar

[14]Mauch RM, Rossi CL, Ribeiro JD, Ribeiro AF, Nolasco da Silva MT, Levy CE. Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA). Diagn Pathol 2014; 9:158. doi:10.1186/s13000-014-0158-zMauchRMRossiCLRibeiroJDRibeiroAFNolascoda Silva MTLevyCEAssessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA)Diagn Pathol2014915810.1186/s13000-014-0158-z418279025146522Open DOISearch in Google Scholar

[15]da Silva Filho LV, Tateno AF, Martins KM, et al. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. Pediatr Pulmonol 2007; 42(10): 938–944. doi:10.1002/ppul.20686daSilva Filho LVTatenoAFMartinsKMet al.The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosisPediatr Pulmonol2007421093894410.1002/ppul.2068617722007Open DOISearch in Google Scholar

[16]Grasemann H, Knauer N, Büscher R, Hübner K, Drazen JM, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 2000;162(6):2172–2176. doi:10.1164/ajrccm.162.6.2003106GrasemannHKnauerNBüscherRHübnerKDrazenJMRatjenFAirway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase geneAm J Respir Crit Care Med200016262172217610.1164/ajrccm.162.6.200310611112133Open DOISearch in Google Scholar

[17]Smith D, Spaněl P, Gilchrist FJ, Lenney W. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection. J Breath Res 2013;7(4):044001. doi:10.1088/1752– 7155/7/4/044001SmithDSpanělPGilchristFJLenneyWHydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infectionJ Breath Res20137404400110.1088/1752–7155/7/4/044001Open DOISearch in Google Scholar

[18]Enderby B, Smith D, Carroll W, Lenney W. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol 2009; 44(2): 142– 147. doi:10.1002/ppul.20963EnderbyBSmithDCarrollWLenneyWHydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis.Pediatr Pulmonol2009442142–14710.1002/ppul.2096319148935Open DOISearch in Google Scholar

[19]Gilchrist F., Belcher J., Jones A.M.,  Smith D., Smyth A.R., Southern K.W.,  Španěl P., Webb A.K., Lenney W. Exhaled breath hydrogen cyanide as a marker of earlyGilchristF.BelcherJ.JonesA.M. SmithD.SmythA.R.SouthernK.W. ŠpanělP.WebbA.K.LenneyW.Exhaled breath hydrogen cyanide as a marker of earlySearch in Google Scholar

[20]Pseudomonas aeruginosa infection in children with cystic fibrosis, ERJ Open ResearchPseudomonas aeruginosa infection in children with cystic fibrosis, ERJ Open ResearchSearch in Google Scholar

[21]2015 1: 00044–2015; DOI: 10.1183/23120541.00044-20152015 1: 00044–2015;10.1183/23120541.00044-2015500512127730156Open DOISearch in Google Scholar

[22]Zhou, X., Li, X., Ye, Y. et al. MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuits. Nat CommunZhouX.LiX.YeYet al.MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuitsNat CommunSearch in Google Scholar

[23]5, 3619 (2014). https://doi.org/10.1038/ncomms46195, 36192014https://doi.org/10.1038/ncomms461910.1038/ncomms4619401155924717937Search in Google Scholar

[24]Dai, L. L., Gao, J. X., Zou, C. G., Ma, Y. C., Zhang, K. Q. Mir-233 modulates the unfolded protein response in C. elegans during Pseudomonas aeruginosa infection. PLoS Pathog 2015 11:e1004606. doi: 10.1371/journal.ppat.1004606DaiL. L.GaoJ. X.ZouC. G.MaY. C.ZhangK. QMir-233 modulates the unfolded protein response in C. elegans during Pseudomonas aeruginosa infectionPLoS Pathog201511e100460610.1371/journal.ppat.1004606428761425569229Open DOISearch in Google Scholar